Literature DB >> 17420661

Collapsing glomerulopathy: an inflammatory podocytopathy?

Laura Barisoni1, Peter J Nelson.   

Abstract

PURPOSE OF REVIEW: Collapsing glomerulopathy is a relatively new and debated podocytopathy. Among several conjectures, inflammatory injury orchestrated by podocytes is emerging to explain the pathogenesis of collapsing glomerulopathy. Here, we briefly summarize recent studies in support of this novel and intriguing hypothesis. RECENT
FINDINGS: Immunohistochemical analyses of markers conventionally used to demarcate podocytes apart from parietal epithelium identified the parietal podocyte. MafB-deficient mice exhibited abnormal podocyte and macrophage differentiation, suggesting ancestral and functional overlap. These apparent developmental anomalies were detected in studies showing an admixture of hyperplastic podocytes with macrophage epitopes and hyperplastic parietal epithelium in pseudocrescents and in true crescents. Experimental antibody-mediated injury of podocytes could trigger capillary collapse and pseudocrescent formation marked by recruitment of epithelial cells from Bowman's capsule. In contrast, experimental stabilization of hypoxia-inducible factors within podocytes--a known inflammatory response by macrophages--could trigger podocyte proliferation and the formation of true necrotizing crescents.
SUMMARY: Preliminary evidence suggests that visceral and parietal podocytes may become macrophage-like inflammatory mediators of proliferative epithelial injury within the glomerulus. This may manifest as collapsing glomerulopathy or crescentic glomerulonephritis--lesions that appear to be anatomically and pathogenically linked.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420661     DOI: 10.1097/MNH.0b013e32805b726b

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  8 in total

1.  A new function for parietal epithelial cells: a second glomerular barrier.

Authors:  Takamoto Ohse; Alice M Chang; Jeffrey W Pippin; George Jarad; Kelly L Hudkins; Charles E Alpers; Jeffrey H Miner; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-30

2.  Crosstalk between protective autophagy and NF-κB signal in high glucose-induced podocytes.

Authors:  Miaomiao Wei; Zhigui Li; Zhuo Yang
Journal:  Mol Cell Biochem       Date:  2014-06-24       Impact factor: 3.396

3.  Collapsing glomerulopathy with rare associated coxsackie virus infection: A case report.

Authors:  Xuejing Zhu; Hong Liu; Shuguang Yuan; Xiangqing Xu; Zhen Dong; Fuyou Liu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

4.  Complete remission of non-HIV collapsing glomerulopathy with deflazacort and lisinopril in an adult patient.

Authors:  Jorge Vega; Francisco Javier Guarda; Helmuth Goecke; Gonzalo P Méndez
Journal:  Clin Exp Nephrol       Date:  2010-04-29       Impact factor: 2.801

Review 5.  Controversies in the pathogenesis of HIV-associated renal diseases.

Authors:  Leslie A Bruggeman; Peter J Nelson
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

6.  Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.

Authors:  Bart Smeets; Maria Lucia Angelotti; Paola Rizzo; Henry Dijkman; Elena Lazzeri; Fieke Mooren; Lara Ballerini; Eliana Parente; Costanza Sagrinati; Benedetta Mazzinghi; Elisa Ronconi; Francesca Becherucci; Ariela Benigni; Eric Steenbergen; Laura Lasagni; Giuseppe Remuzzi; Jack Wetzels; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

Review 7.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10

8.  TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.

Authors:  Leslie A Bruggeman; Paul E Drawz; Nicole Kahoud; Ke Lin; Laura Barisoni; Peter J Nelson
Journal:  Lab Invest       Date:  2011-01-10       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.